This work was partly supported by the Natural Science and Engineering Research Council (NSERC) of Canada.
More than a million metallic endovascular devices are implanted each year, but the quest for the perfect material continues. The importance of interfacial properties in the overall biocompatibility of metals and alloys has been recognized for a long time. In particular, these properties modulate the hemocompatibility of devices in contact with blood and, in turn, strongly influence implantation outcomes. In this article, the relative properties of metallic materials commonly used in endovascular applications are reviewed. Particular emphasis is given to the corrosion behavior of metallic endovascular materials and the specific surface treatments used in the production processes. Issues relative to corrosion assays will also be reviewed in terms of their relevance to in vivo applications. The potential adverse effects of degradation products with respect to endovascular applications will be described. Finally, this review addresses future perspectives of metallic devices in endovascular procedures in view of the recent promises of antiproliferative strategies that are likely to profoundly modify current procedures.
ThierryBMerhiYBilodeauL. Nitinol versus stainless steel stents: Acute thrombogenicity study in an ex vivo porcine model. Biomaterials. 2002; 23: 2997–3005.
2.
ChwirutDJOktayHSRyanT. Nitinol interventional cardiology devices—FDA's perspective. In: PeltonAHodgsonDRussellS, eds. SMST 97: Proceedings of the Second International Conference on Shape Memory and Superelastic Technologies. Santa Clara, CA: SMST; 1997.
3.
DisegiJZardiackasL. Retrieval analysis of stainless steel plate/screws implanted for 55 years [Abstract]. In: Proceeding of the 27th Meeting of the Society for Biomaterials. Mt. Laurel, NJ: Society for Biomaterials; 2000.
4.
GuidoinRMaroisYDouvilleY. First-generation aortic endografts: Analysis of explanted Stentor devices from the EUROSTAR registry. J Endovasc Ther.2000; 7: 105–122.
5.
HeintzCRiepeGBirkenL. Corroded nitinol wires in explanted aortic endografts: An important mechanism of failure?J Endovasc Ther.2001; 8: 248–253.
6.
KosterRVielufDKiehnM. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet. 2000; 356: 1895–1897.
7.
KastratiASchomigADirschingerJ. Increased risk of restenosis after placement of gold-coated stents: Results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. Circulation. 2000; 101: 2478–2483.
VenugopalanRTrépanierC. Assessing the corrosion behaviour of nitinol for minimally-invasive device design. Minim Invasive Ther Allied Technol.2000; 9: 67–74.
10.
GershlickAH. Role of stenting in coronary revascularisation. Heart. 2001; 86: 104–112.
11.
NarinsCREllisSG. Prevention of in-stent restenosis. Semin Interv Cardiol.1998; 3: 91–103.
12.
StoeckelD. Nitinol medical devices and implants. Minim Invasive Ther Allied Technol.2000; 9: 81–88.
13.
PeltonARDiCelloJMiyazakiS. Optimisation of processing and properties of medical grade nitinol wire. Minim Invasive Ther Allied Technol.2000; 9: 107–118.
14.
BhargavaBDe ScheerderIPingQB. A novel platinum-iridium, potentially gamma radioactive stent: Evaluation in a porcine model. Catheter Cardiovasc Interv.2000; 51: 364–368.
15.
van DijkLCvan HoltenJvan DijkBP. A precious metal alloy for construction of MR imaging-compatible balloon-expandable vascular stents. Radiology. 2001; 219: 284–287.
16.
MankeCNitzWRLenhartM. Magnetic resonance monitoring of stent deployment: In vitro evaluation of different stent designs and stent delivery systems. Invest Radiol.2000; 35: 343–351.
17.
MaintzDFischbachRJuergensKU. Multislice CT angiography of the iliac arteries in the presence of various stents: In vitro evaluation of artifacts and lumen visibility. Invest Radiol.2001; 36: 699–704.
18.
HeubleinBRohdeRKaeseV. Biocorrosion of magnesium alloys: A new principle in cardiovascular implant technology?Heart. 2003; 89: 651–656.
19.
PeusterMWohlseinPBrugmannM. A novel approach to temporary stenting: Degradable cardiovascular stents produced from corrodible metal—results 6–18 months after implantation into New Zealand white rabbits. Heart. 2001; 86: 563–569.
20.
ASTM F86. Standard Practice for Surface Preparation and Marking of Metallic Surgical Implants. In: Annual Book of ASTM Standards: Medical Devices and Services, Vol. 13.01. Philadelphia: American Society for Testing and Materials; 1995: 6–8.
21.
TrépanierCTabrizianMYahiaLH. Effect of modification of oxide layer on NiTi stent corrosion resistance. J Biomed Mater Res.1998; 43: 433–440.
ClarkGCWilliamsDF. The effects of proteins on metallic corrosion. J Biomed Mater Res.1982; 16: 125–134.
24.
KhanMAWilliamsRLWilliamsDF. The corrosion behaviour of Ti-6Al–4V, Ti-6Al–7Nb and Ti-13Nb–13Zr in protein solutions. Biomaterials. 1999; 20: 631–637.
25.
WatahaJCNelsonSKLockwoodPE. Elemental release from dental casting alloys into biological media with and without protein. Dent Mater. 2001; 17: 409–414.
26.
MilosevIStrehblowHH. The behavior of stainless steels in physiological solution containing complexing agent studied by X-ray photoelectron spectroscopy. J Biomed Mater Res.2000; 52: 404–412.
27.
MuYKobayashiTSumitaM. Metal ion release from titanium with active oxygen species generated by rat macrophages in vitro. J Biomed Mater Res.2000; 49: 238–243.
28.
HutchinsonBSBaumgardnerJD. Evaluation of the effect of cells on the corrosion behavior of implant alloys [Abstract]. In: Proceedings of the World Biomaterials Congress. Mt. Laurel, NJ: Society for Biomaterials; 2000.
29.
WoodmanJLBlackJJiminezSA. Isolation of serum protein organometallic corrosion products from 316LSS and HS-21 in vitro and in vivo. J Biomed Mater Res.1984; 18: 99–114.
30.
JacobsJJSkiporAKPattersonLM. Metal release in patients who have had a primary total hip arthroplasty. A prospective, controlled, longitudinal study. J Bone Joint Surg Am. 1998; 80: 1447–1458.
EmanuelliGGattiAMCigadaA. Physico-chemical observations on a failed Greenfield vena cava filter. J Cardiovasc Surg (Torino). 1995; 36: 121–125.
34.
McKelveyALRitchieRO. Fatigue-crack propagation in Nitinol, a shape-memory and superelastic endovascular stent material. J Biomed Mater Res.1999; 47: 301–308.
35.
ReclaruLLerfREschlerPY. Pitting, crevice and galvanic corrosion of REX stainless-steel/CoCr orthopedic implant material. Biomaterials. 2002; 23: 3479–3485.
36.
ASTM G5. Standard Reference Test Method for Making Potentiostatic and Potentiodynamic Anodic Polarization Measurements. In: Annual Book of ASTM Standards: Metals, Test Methods and Analytical Procedures. Philadelphia: American Society for Testing and Materials; 1995: 48–58.
37.
ASTM G102. Standard Practice for Calculation of Corrosion Rates and Related Information From Electrochemical Measurements. In: Annual Book of ASTM Standards: Metals, Test Methods and Analytical Procedures. Philadelphia: American Society for Testing and Materials; 1995: 401–407.
38.
ASTM F746. Standard Test Method for Pitting or Crevice Corrosion of Metallic Surgical Implant Materials. In: Annual Book of ASTM Standards: Metals, Test Methods and Analytical Procedures. Philadelphia: American Society for Testing and Materials; 1995: 192–197.
39.
TrépanierCVenugopalanRMesserR. Effect of passivation treatments on nickel release from nitinol [Abstract]. In: Proceeding of the World Biomaterials Congress. Mt. Laurel, NJ: Society for Biomaterials; 2000.
40.
FiliPLausmaaJMusialekJ. Structure and surface of TiNi human implants. Biomaterials. 2001; 22: 2131–2138.
41.
ThierryBTabrizianMTrépanierC. Effect of surface treatment and sterilization processes on the corrosion behavior of NiTi shape memory alloy. J Biomed Mater Res.2000; 51: 685–693.
42.
RyhanenJNiemiESerloW. Biocompatibility of nickel-titanium shape memory metal and its corrosion behavior in human cell cultures. J Biomed Mater Res.1997; 35: 451–457.
43.
WeverDJVeldhuizenAGde VriesJ. Electrochemical and surface characterization of a nickel-titanium alloy. Biomaterials. 1998; 19: 761–769.
44.
RondelliG. Corrosion resistance tests on NiTi shape memory alloy. Biomaterials. 1996; 17: 2003–2008.
45.
VenugopalanR. Corrosion testing of stents: A novel fixture to hold entire device in deployed form and finish. J Biomed Mater Res.1999; 48: 829–832.
46.
ClercCOJedwabMRMayerDW. Assessment of wrought ASTM F1058 cobalt alloy properties for permanent surgical implants. J Biomed Mater Res.1997; 38: 229–234.
47.
GotmanI. Characteristics of metals used in implants. J Endourol.1997; 11: 383–389.
48.
GarasicJMEdelmanERSquireJC. Stent and artery geometry determine intimal thickening independent of arterial injury. Circulation. 2000; 101: 812–818.
49.
KastratiAMehilliJDirschingerJ. Intracoronary stenting and angiographic results: Strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation. 2001; 103: 2816–2821.
50.
HoffmannRJansenCKonigA. Stent design related neointimal tissue proliferation in human coronary arteries; an intravascular ultrasound study. Eur Heart J.2001; 22: 2007–2014.
51.
YoshitomiYKojimaSYanoM. Does stent design affect probability of restenosis? A randomized trial comparing Multilink stents with GFX stents. Am Heart J.2001; 142: 445–451.
52.
KastratiAMehilliJDirschingerJ. Restenosis after coronary placement of various stent types. Am J Cardiol.2001; 87: 34–39.
53.
GunnJCumberlandD. Does stent design influence restenosis?Eur Heart J.1999; 20: 1009–1013.
54.
DyetJFWattsWGEttlesDF. Mechanical properties of metallic stents: How do these properties influence the choice of stent for specific lesions?Cardiovasc Intervent Radiol.2000; 23: 47–54.
55.
ShethSLitvackFDevV. Subacute thrombosis and vascular injury resulting from slotted-tube nitinol and stainless steel stents in a rabbit carotid artery model. Circulation. 1996; 94: 1733–1740.
56.
CarterAJScottDLairdJR. Progressive vascular remodeling and reduced neointimal formation after placement of a thermoelastic self-expanding nitinol stent in an experimental model. Cathet Cardiovasc Diagn.1998; 44: 193–201.
57.
HarnekJZoucasECarlemalmE. Differences in endothelial injury after balloon angioplasty, insertion of balloon-expanded stents or release of self-expanding stents: An electron microscopic experimental study. Cardiovasc Intervent Radiol.1999; 22: 56–61.
58.
YuZXTamaiHKyoE. Comparison of the self-expanding Radius stent and the balloon-expandable Multilink stent for elective treatment of coronary stenoses: A serial analysis by intravascular ultrasound. Catheter Cardiovasc Interv.2002; 56: 40–45.
59.
RoguinAGrenadierELinnS. Continued expansion of the nitinol self-expanding coronary stent: Angiographic analysis and 1-year clinical follow-up. Am Heart J.1999; 138: 326–333.
60.
TaylorAJGormanPDKenwoodB. A comparison of four stent designs on arterial injury, cellular proliferation, neointima formation, and arterial dimensions in an experimental porcine model. Catheter Cardiovasc Interv.2001; 53: 420–425.
61.
MukherjeeDKalahastiVRoffiM. Self-expanding stents for carotid interventions: Comparison of nitinol versus stainless-steel stents. J Invasive Cardiol.2001; 13: 732–735.
62.
BrashJL. Exploiting the current paradigm of blood-material interactions for the rational design of blood-compatible materials. J Biomater Sci Polym Ed. 2000; 11: 1135–1146.
EtoKGotoSShimazakiT. Two distinct mechanisms are involved in stent thrombosis under flow conditions. Platelets. 2001; 12: 228–235.
65.
JanatovaJ. Activation and control of complement, inflammation, and infection associated with the use of biomedical polymers. ASAIO J.2000; 46: S53–62.
66.
BasmadjianDSeftonMVBaldwinSA. Coagulation on biomaterials in flowing blood: Some theoretical considerations. Biomaterials. 1997; 18: 1511–1522.
67.
VoglerEA. Water and the acute biological response to surfaces. J Biomater Sci Polym Ed. 1999; 10: 1015–1045.
68.
SimonCPalmazJCSpragueEA. Protein interactions with endovascular prosthetic surfaces. J Long Term Eff Med Implants. 2000; 10: 127–141.
69.
ParkJYGemmellCHDaviesJE. Platelet interactions with titanium: Modulation of platelet activity by surface topography. Biomaterials. 2001; 22: 2671–2682.
70.
SpragueEAPalmazJCSimonC. Electrostatic forces on the surface of metals as measured by atomic force microscopy. J Long Term Eff Med Implants. 2000; 10: 111–125.
71.
WilliamsDF. Biomaterials and biocompatibility: An introduction. In: WilliamsDF, ed. Fundamental Aspects of Biocompatibility. Boca Raton: CRC Press; 1981: 2–3.
72.
RyhanenJKallioinenMTuukkanenJ. In vivo biocompatibility evaluation of nickel-titanium shape memory metal alloy: Muscle and perineural tissue responses and encapsule membrane thickness. J Biomed Mater Res.1998; 41: 481–488.
73.
MatsunoHYokoyamaAWatariF. Biocompatibility and osteogenesis of refractory metal implants, titanium, hafnium, niobium, tantalum and rhenium. Biomaterials. 2001; 22: 1253–1262.
74.
TrépanierCLeungTKTabrizianM. Preliminary investigation of the effects of surface treatments on biological response to shape memory NiTi stents. J Biomed Mater Res.1999; 48: 165–171.
75.
FormichiMMaroisYRobyP. Endovascular repair of thoracic aortic aneurysm in dogs: Evaluation of a nitinol-polyester self-expanding stent-graft. J Endovasc Ther.2000; 7: 47–67.
76.
GearyRLNikkariSTWagnerWD. Wound healing: A paradigm for lumen narrowing after arterial reconstruction. J Vasc Surg.1998; 27: 96–108.
77.
VaheyJWSimonianPTConradEU. Carcinogenicity and metallic implants. Am J Orthop. 1995; 24: 319–324.
78.
ShihCCShihCMChenYL. Growth inhibition of cultured smooth muscle cells by corrosion products of 316 L stainless steel wire. J Biomed Mater Res.2001; 57: 200–207.
79.
ShihCCLinSJChenYL. The cytotoxicity of corrosion products of nitinol stent wire on cultured smooth muscle cells. J Biomed Mater Res.2000; 52: 395–403.
80.
WatahaJCO'DellNLSinghBB. Relating nickel-induced tissue inflammation to nickel release in vivo. J Biomed Mater Res.2001; 58: 537–544.
81.
UoMWatariFYokoyamaA. Dissolution of nickel and tissue response observed by X-ray scanning analytical microscopy. Biomaterials. 1999; 20: 747–755.
82.
SchmalzGSchusterUSchweiklH. Influence of metals on IL-6 release in vitro. Biomaterials. 1998; 19: 1689–1694.
83.
WatahaJCLockwoodPEMarekM. Ability of Ni-containing biomedical alloys to activate monocytes and endothelial cells in vitro. J Biomed Mater Res.1999; 45: 251–257.
84.
WatahaJCRatanasathienSHanksCT. In vitro IL-1 beta and TNF-alpha release from THP-1 monocytes in response to metal ions. Dent Mater. 1996; 12: 322–327.
85.
BudingerLHertlM. Immunologic mechanisms in hypersensitivity reactions to metal ions: An overview. Allergy. 2000; 55: 108–115.
86.
ThomssenHHoffmannBSchankM. Cobalt-specific T lymphocytes in synovial tissue after an allergic reaction to a cobalt alloy joint prosthesis. J Rheumatol.2001; 28: 1121–1128.
87.
HallabNMerrittKJacobsJJ. Metal sensitivity in patients with orthopaedic implants. J Bone Joint Surg Am. 2001; 83-A: 428–436.
RensingBJVosJSmitsPC. Coronary restenosis elimination with a sirolimus eluting stent: First European human experience with 6-month angiographic and intravascular ultrasonic follow-up. Eur Heart J.2001; 22: 2125–2130.
90.
HeldmanAWChengLJenkinsGM. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation. 2001; 103: 2289–2295.
91.
FoxR. American Heart Association 2001 scientific sessions: Late-breaking science—drug-eluting stents. Circulation. 2001; 104: E9052.
92.
SousaJECostaMAAbizaidAC. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: One-year angiographic and intravascular ultrasound follow-up. Circulation. 2001; 104: 2007–2011.
WaksmanRRaiznerAEYeungAC. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: The INHIBIT randomised controlled trial. Lancet. 2002; 359: 551–557.
95.
LoweHCOesterleSNKhachigianLM. Coronary in-stent restenosis: Current status and future strategies. J Am Coll Cardiol.2002; 39: 183–193.
96.
SerruysPWKayIP. I like the candy, I hate the wrapper: The (32)P radioactive stent. Circulation. 2000; 101: 3–7.
LiistroFGimelliGDi MarioC. Late acute thrombosis after coronary brachytherapy: When is the risk over?Catheter Cardiovasc Interv.2001; 54: 216–218.
99.
LiistroFColomboA. Late acute thrombosis after paclitaxel eluting stent implantation. Heart. 2001; 86: 262–264.
100.
BrennerDJMillerRC. Long-term efficacy of intracoronary irradiation in inhibiting in-stent restenosis. Circulation. 2001; 103: 1330–1332.
101.
LiistroFStankovicGDi MarioC. First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: Immediate and long-term clinical and angiographic outcome. Circulation. 2002; 105: 1883–1886.
102.
LewisALCummingZLGoreishHH. Crosslinkable coatings from phosphorylcholine-based polymers. Biomaterials. 2001; 22: 99–111.
103.
LewisALTolhurstLAStratfordPW. Analysis of a phosphorylcholine-based polymer coating on a coronary stent pre- and postimplantation. Biomaterials. 2002; 23: 1697–1706.
104.
GrenadierERoguinAHertzI. Stenting very small coronary narrowings (<2 mm) using the biocompatible phosphorylcholine-coated coronary stent. Catheter Cardiovasc Interv.2002; 55: 303–308.
105.
NelsonSRdeSouzaNMAllisonDJ. Endovascular stents and stent-grafts: Is heparin coating desirable?Cardiovasc Intervent Radiol.2000; 23: 252–255.
106.
VrolixMCLegrandVMReiberJH. Heparin-coated Wiktor stents in human coronary arteries (MENTOR trial). MENTOR Trial Investigators. Am J Cardiol.2000; 86: 385–389.
107.
van der GiessenWJvan BeusekomHMEijgelshovenMH. Heparin-coating of coronary stents. Semin Interv Cardiol.1998; 3: 173–176.
108.
KocsisJFLlanosGHolmerE. Heparin-coated stents. J Long Term Eff Med Implants. 2000; 10: 19–45.
109.
LahannJKleeDPluesterW. Bioactive immobilization of r-hirudin on CVD-coated metallic implant devices. Biomaterials. 2001; 22: 817–826.
110.
NanHPingYXuanC. Blood compatibility of amorphous titanium oxide films synthesized by ion beam enhanced deposition. Biomaterials. 1998; 19: 771–776.
111.
GutensohnKBeythienCBauJ. In vitro analyses of diamond-like carbon coated stents. Reduction of metal ion release, platelet activation, and thrombogenicity. Thromb Res.2000; 99: 577–585.
112.
HeubleinBÖzbekCPethigK. Silicon carbide-coated stents: Clinical experience in coronary lesions with increased thrombotic risk. J Endovasc Surg.1998; 5: 32–36.
113.
WindeckerSMayerIDe PasqualeG. Stent coating with titanium-nitride-oxide for reduction of neointimal hyperplasia. Circulation. 2001; 104: 928–933.
114.
YasudaSNoguchiTGohdaM. Local delivery of low-dose docetaxel, a novel microtubule polymerizing agent, reduces neointimal hyperplasia in a balloon-injured rabbit iliac artery model. Cardiovasc Res.2002; 53: 481–486.
115.
SturekMReddyHK. New tools for prevention of restenosis could decrease the “oculostento” reflex. Cardiovasc Res.2002; 53: 292–293.
116.
SuzukiTHayaseMHibiK. Effect of local delivery of L-arginine on in-stent restenosis in humans. Am J Cardiol.2002; 89: 363–367.
